SCHEMBL1230754

SCHEMBL1230754

CC(N)C1COOC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14744233 0.81
SCHEMBL14737710 0.81
SCHEMBL29192982 0.81
Hydrochloric Acid SCHEMBL20659484 0.79
Hydrochloric Acid SCHEMBL29821508 0.79
Hydrochloric Acid SCHEMBL20659482 0.77
SCHEMBL6052759 0.73
SCHEMBL25330340 0.69 SLC22A2 (0.35)
SCHEMBL511273 0.69
SCHEMBL635168 0.69 ROCK2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4370136-A2 SIMPLE CHEMICAL APPROACHES TO INTRODUCE 2,6-DIAMINOPURINE AND 2-AMINOADENINE CONJUGATES INTO OLIGONUCLEOTIDES Alnylam Pharmaceuticals, Inc. (US) 2024-05-22 EP disclosed
WO-2023288045-A2 SIMPLE CHEMICAL APPROACHES TO INTRODUCE 2,6-DIAMINOPURINE AND 2-AMINOADENINE CONJUGATES INTO OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-19 WO disclosed
EP-3934700-A1 NON-ACTIVE LIPID NANOPARTICLES WITH NON-VIRAL, CAPSID FREE DNA Generation Bio Co. (US) 2022-01-12 EP disclosed
WO-2018136620-A2 ENDOSOMAL CLEAVABLE LINKERS ALNYLAM PHARMACEUTICALS, INC. (US) 2018-07-26 WO disclosed
WO-2015112809-A2 NSD3 INHIBITORS FOR TREATMENT OF CANCERS THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2015-07-30 WO disclosed
WO-2013188787-A1 INHIBITORS OF MICRORNAs THAT REGULATE PRODUCTION OF ATRIAL NATRIURETIC PEPTIDE (ANP) AS THERAPEUTICS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2013-12-19 WO disclosed
WO-2011017137-A2 METHODS AND COMPOSITIONS FOR TREATING INSECTS ALNYLAM PHARMACEUTICALS, INC. (US) 2011-02-10 WO disclosed